REGN1033 (SAR391786)

DRUG3 trials

Sponsors

Regeneron Pharmaceuticals

Conditions

Healthy VolunteersSarcopenia

Phase 1

Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1033 (SAR391786)

CompletedNCT01720576

Regeneron PharmaceuticalsHealthy Volunteers

Start: 2012-10-31End: 2013-06-30Updated: 2013-09-12

Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)

CompletedNCT01910220

Regeneron PharmaceuticalsHealthy Volunteers

Start: 2013-08-31End: 2014-10-31Updated: 2014-11-10

Phase 2

Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia

CompletedNCT01963598

Regeneron PharmaceuticalsSarcopenia

Start: 2013-11-30End: 2015-02-28Updated: 2016-03-28